Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × famitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Triple Negative Breast Neoplasms 4 Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Small Cell Lung Carcinoma 2 Ovarian Neoplasms 2 Gastrointestinal Stromal Tumors 2 Colorectal Neoplasms 2 Cervical Cancer Metastatic 2 Carcinoma, Renal Cell 2 Thyroid Neoplasms 1 Solid Tumor 1 Recurrence 1 Non Squamous Non Small Cell Lung 1 Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Melanoma 1 Gastro-enteropancreatic neuroendocrine tumor 1 Esophageal Squamous Cell Carcinoma 1 Endometrial Neoplasms 1 Disease Progression 1 Cholangiocarcinoma 1 Carcinoma, Transitional Cell 1 BRCA-Mutated Breast Carcinoma 1 Advanced Solid Tumor 1 Advanced NSCLC 1

Interventions

pembrolizumab 129 Gemcitabine 115 Capecitabine 107 Fluorouracil 99 Paclitaxel 98 Bevacizumab 91 Oxaliplatin 89 Nivolumab 86 Leucovorin 81 Docetaxel 80 Radiosurgery 79 Irinotecan 72 Carboplatin 70 Cisplatin 69 Cetuximab 61 Cyclophosphamide 60 Magnetic Resonance Spectroscopy 59 Specimen Handling 54 Biopsy 53 Radiotherapy 48 Trastuzumab 47 Ipilimumab 44 Drug Therapy 43 Pemetrexed 38 Everolimus 38 Albumin-Bound Paclitaxel 37 130-nm albumin-bound paclitaxel 37 Fulvestrant 36 Doxorubicin 34 aldesleukin 32

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04355858 2022-07-26

MULAN

Fudan University

Phase 2 Unknown

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡